11 completed, 4 terminated, 3 unknown, 3 withdrawn. 22 Phase 2, 9 Phase 1, 5 Phase 3.
Follow Fecal Incontinence: new trials by email Literature Review of Fecal Incontinence trials Research Report on Fecal Incontinence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis Diaper with a copper-based product + usual care, Barrier product with common diaper - Incontinence-associated Dermatitis | Phase 2 / Phase 3 | Withdrawn | Hospital Israelita Albert Einstein | 2025-09-01 | 2026-01-12 | |
| The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence Ramosetron, Psyllium - Fecal Incontinence | Phase 2 / Phase 3 | Active not recruiting | Seoul National University Hospital | 147 | 2024-01-19 | 2026-10-27 |
| Lidocaine Patches Prior to Percutaneous Nerve Evaluation Lidocaine patch, Placebo - Overactive Bladder, Urge Incontinence | Phase 2 | Completed | University of Louisville | 39 | 2023-05-01 | 2025-02-03 |
| A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection BOTOX-A - Low Anterior Resection Syndrome (LARS>20), Refractory Medical Treatment After Rectal Resection | Phase 2 | Terminated | University Hospital, Bordeaux | 11 | 2021-09-01 | 2023-10-27 |
| Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women fecal microbial transplantation (FMT) - Fecal Incontinence | Phase 1 / Phase 2 | Terminated | University of Pennsylvania | 10 | 2021-01-14 | 2024-06-12 |
| Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence Eluxadoline 100 mg, Placebo - Fecal Incontinence, Accidental Bowel Leakage | Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2019-04-01 | 2019-07-25 | |
| Bulking Agent Versus Electrostimulation Therapy in Anal Incontinence Bulking agent, Endoanal electrostimulation - Fecal Incontinence | Phase 2 / Phase 3 | Unknown | University of Sao Paulo | 60 | 2018-02-28 | 2018-02-06 |
| Treating Anorectal Dysfunction in MS Bisacodyl, Placebo - Constipation, Fecal Incontinence | Phase 2 | Terminated | David Levinthal | 11 | 2016-06-01 | 2020-01-22 |
| The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients Oxymetazoline gel, Placebo gel - Fecal Incontinence, Spinal Cord Injury | Phase 1 / Phase 2 | Completed | RDD Pharma Ltd | 19 | 2014-11-01 | 2015-07-28 |
| Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence low fodmap diet, Psyllium - Fecal Incontinence | Phase 2 | Completed | University of Michigan | 40 | 2014-10-02 | 2019-08-28 |
| Stem Cells Therapy for Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty Stem Cells Injection Technique, Stem Cell Isolation - Fecal Incontinence | Phase 1 / Phase 2 | Unknown | Al-Azhar University | 50 | 2013-10-01 | 2014-06-11 |
| Autologous Cell Therapy for Treatment of Fecal Incontinence Iltamiocel - Fecal Incontinence | Phase 1 / Phase 2 | Completed | Cook MyoSite | 53 | 2013-03-28 | 2024-02-16 |
| Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence Myoblast injection, saline solution injection - Fecal Incontinence | Phase 2 / Phase 3 | Completed | University Hospital, Rouen | 24 | 2012-02-01 | 2015-10-23 |
| A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence alpha agonist ointment, Placebo - Idiopathic Fecal Incontinence | Phase 1 / Phase 2 | Withdrawn | RDD Pharma Ltd | 2011-08-01 | 2013-12-12 | |
| An Study to Examine the Effect of Coated Suppositories on Anal Pressure in Healthy Subjects coated suppository - Fecal Incontinence | Phase 1 / Phase 2 | Completed | RDD Pharma Ltd | 6 | 2011-08-01 | 2011-08-23 |
| Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence active stimulation, sham stimulation - Fecal Incontinence | Phase 2 | Completed | University Hospital, Rouen | 144 | 2009-10-01 | 2011-08-23 |
| Pilot Study of NASHA/Dx Gel for Fecal Incontinence Solesta (Nasha/Dx) - Fecal Incontinence | Phase 1 / Phase 2 | Unknown | Uppsala University Hospital | 16 | 2009-01-01 | 2009-09-03 |
| A Placebo-Controlled Study of Clonidine for Fecal Incontinence. Clonidine, Placebo - Fecal Incontinence | Phase 2 | Completed | Mayo Clinic | 44 | 2008-10-01 | 2014-03-06 |
| Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence Psyllium powder, Loperamide - Fecal Incontinence | Phase 2 / Phase 3 | Completed | US Department of Veterans Affairs | 80 | 2008-07-01 | 2015-04-01 |
| Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms TOPAS - Fecal Incontinence | Phase 1 / Phase 2 | Completed | ASTORA Women's Health | 29 | 2007-09-01 | 2016-05-23 |
Showing 20 of 22. Sign in to see all of them.
Diarrhea (2) · Encopresis (2) · Urinary Incontinence (2) · Urinary Incontinence, Urge (2) · Constipation (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Low Anterior Resection Syndrome (1) · Multiple Sclerosis (1) · Rectal Diseases (1) · Spinal Cord Injuries (1) · Urinary Bladder, Overactive (1)
Digestive System Diseases (22) · Gastrointestinal Diseases (21) · Intestinal Diseases (21) · Rectal Diseases (21) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (6) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Lower Urinary Tract Symptoms (4) · Male Urogenital Diseases (4) · Signs and Symptoms, Digestive (4) · Urination Disorders (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Urological Manifestations (4)
Psyllium (3) · Bisacodyl (1) · Botulinum Toxins, Type A (1) · Clonidine (1) · FODMAP Diet (1) · Loperamide (1) · Saline Solution (1) · Sugars (1) · dextranomer-hyaluronic acid copolymer (1) · eluxadoline (1) · ramosetron (1)
RDD Pharma Ltd (3) · University Hospital, Rouen (2) · Uppsala University Hospital (2) · ASTORA Women's Health (1) · Al-Azhar University (1) · Carbon Medical Technologies (1) · Cook MyoSite (1) · David Levinthal (1) · Hospital Israelita Albert Einstein (1) · Mayo Clinic (1) · Seoul National University Hospital (1) · US Department of Veterans Affairs (1) · University Hospital, Bordeaux (1) · University of Louisville (1) · University of Michigan (1)
United States (7) · France (3) · Israel (2) · Sweden (2) · Canada (1) · Egypt (1) · Hungary (1) · South Korea (1) · United Kingdom (1)
Abdel-Wahab El-Okby, MD (1) · Adil E Bharucha, M.D. (1) · Alayne D Markland, DO MSc (1) · Anders Mellgren, MD, PhD (1) · Anthony Atala, MD (1) · David J Levinthal, MD, PhD (1) · Hala Gabr, MD (1) · Manoj J Raval, MD (1) · Michael Shapiro, MD (1) · Mostafa Elbahrawy, MSc (1) · Naglaa Ali Gadallah, MD (1) · Refaat El-Badawy, MD (1)
PMID 19581853, PMID 23891925, PMID 24763157, PMID 25565635, PMID 35060943, PMID 37144409, PMID 40013530
R01DK078924 (1), UL1RR024150 (1)